WG Tech JiangXi Co Ltd
SSE:603773
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
W
|
WG Tech JiangXi Co Ltd
SSE:603773
|
CN |
|
V
|
Vcanbio Cell & Gene Engineering Corp Ltd
SSE:600645
|
CN |
Balance Sheet
Balance Sheet Decomposition
WG Tech JiangXi Co Ltd
WG Tech JiangXi Co Ltd
Balance Sheet
WG Tech JiangXi Co Ltd
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
166
|
149
|
181
|
871
|
714
|
475
|
298
|
374
|
608
|
611
|
|
| Cash |
166
|
149
|
181
|
871
|
710
|
468
|
298
|
374
|
608
|
611
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
4
|
7
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
67
|
31
|
|
| Total Receivables |
108
|
187
|
289
|
240
|
248
|
279
|
601
|
1 037
|
1 054
|
1 201
|
|
| Accounts Receivables |
101
|
176
|
279
|
215
|
204
|
249
|
539
|
920
|
950
|
1 022
|
|
| Other Receivables |
6
|
11
|
11
|
25
|
44
|
31
|
62
|
117
|
105
|
178
|
|
| Inventory |
3
|
7
|
16
|
18
|
23
|
22
|
136
|
121
|
140
|
123
|
|
| Other Current Assets |
4
|
5
|
7
|
5
|
5
|
26
|
17
|
146
|
47
|
177
|
|
| Total Current Assets |
281
|
348
|
493
|
1 134
|
990
|
802
|
1 053
|
1 678
|
1 917
|
2 143
|
|
| PP&E Net |
315
|
391
|
449
|
571
|
727
|
1 022
|
1 156
|
1 095
|
1 431
|
1 839
|
|
| PP&E Gross |
0
|
391
|
449
|
571
|
727
|
1 022
|
1 156
|
1 095
|
1 431
|
1 839
|
|
| Accumulated Depreciation |
0
|
78
|
112
|
156
|
214
|
316
|
452
|
737
|
773
|
808
|
|
| Intangible Assets |
35
|
35
|
34
|
39
|
38
|
111
|
109
|
106
|
108
|
117
|
|
| Goodwill |
0
|
38
|
38
|
38
|
38
|
38
|
241
|
204
|
198
|
190
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
4
|
2
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
17
|
0
|
81
|
100
|
79
|
|
| Other Long-Term Assets |
5
|
4
|
5
|
16
|
17
|
23
|
46
|
56
|
60
|
65
|
|
| Other Assets |
0
|
38
|
38
|
38
|
38
|
38
|
241
|
204
|
198
|
190
|
|
| Total Assets |
636
N/A
|
815
+28%
|
1 019
+25%
|
1 797
+76%
|
1 809
+1%
|
2 013
+11%
|
2 605
+29%
|
3 220
+24%
|
3 816
+18%
|
4 434
+16%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
61
|
55
|
75
|
92
|
156
|
141
|
333
|
630
|
679
|
913
|
|
| Accrued Liabilities |
24
|
25
|
69
|
39
|
19
|
28
|
71
|
60
|
43
|
55
|
|
| Short-Term Debt |
0
|
77
|
40
|
18
|
1
|
211
|
364
|
835
|
828
|
876
|
|
| Current Portion of Long-Term Debt |
0
|
20
|
20
|
0
|
0
|
0
|
49
|
63
|
99
|
135
|
|
| Other Current Liabilities |
0
|
19
|
12
|
8
|
5
|
7
|
28
|
17
|
25
|
27
|
|
| Total Current Liabilities |
85
|
195
|
215
|
158
|
181
|
387
|
844
|
1 604
|
1 673
|
2 006
|
|
| Long-Term Debt |
99
|
80
|
60
|
0
|
0
|
0
|
27
|
91
|
551
|
931
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
103
|
128
|
163
|
178
|
|
| Other Liabilities |
27
|
14
|
10
|
10
|
12
|
10
|
99
|
20
|
52
|
63
|
|
| Total Liabilities |
211
N/A
|
289
+37%
|
285
-1%
|
168
-41%
|
193
+15%
|
397
+106%
|
1 074
+170%
|
1 845
+72%
|
2 440
+32%
|
3 180
+30%
|
|
| Equity | |||||||||||
| Common Stock |
70
|
71
|
71
|
95
|
95
|
95
|
122
|
171
|
171
|
223
|
|
| Retained Earnings |
130
|
205
|
413
|
571
|
557
|
556
|
524
|
184
|
180
|
47
|
|
| Additional Paid In Capital |
224
|
250
|
250
|
964
|
964
|
964
|
938
|
1 019
|
1 026
|
985
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
53
|
0
|
3
|
2
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
|
| Total Equity |
424
N/A
|
526
+24%
|
734
+39%
|
1 630
+122%
|
1 616
-1%
|
1 615
0%
|
1 532
-5%
|
1 376
-10%
|
1 376
+0%
|
1 255
-9%
|
|
| Total Liabilities & Equity |
636
N/A
|
815
+28%
|
1 019
+25%
|
1 797
+76%
|
1 809
+1%
|
2 013
+11%
|
2 605
+29%
|
3 220
+24%
|
3 816
+18%
|
4 434
+16%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
70
|
71
|
71
|
95
|
95
|
95
|
203
|
226
|
223
|
223
|
|